References
- Jaffe EA. Physiologic functions of normal endothelial cells. In: Loscalzo J, Creager MA, Dzau VJ, eds. Vascular medicine: a textbook of vascular biology and diseases. Boston: Little, Brown, 1992:3–46
- Hawigen J. Interaction of platelets and other cellular elements with the vessel wall. In: Loscalzo et al, eds1
- Albrink MJ, Man EB. Serum triglycerides in coronary artery disease. Arch Intern Med 1959;103:4–8
- Hulley SB, Rosenman RH, Bawol RD, et al. Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 1980:302(25): 1383–9
- Tobert JA. Efficacy and long-term adverse effect pattern of lovastatin. Am J Cardiol 1988; 62:28J–34J
- Waclawik AJ, Lindal S, Engel AG. Experimental lovastatin myopathy. J Neuropath Exp Neurol 1993;52:542–9
- Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. (Editorial) Am J Cardiol 1992;70(9):945–9
- Squires RW, Allison TG, Gau GT, et al. Low-dose, time-release nicotinic acid: effects in selected patients with low concentrations of high-density lipoprotein cholesterol. Mayo Clin Proc 1992;67(9):855–60
- Briones ER, Palumbo PJ, Kottke BA, et al. Nutrition, metabolism, and blood lipids in humans with type II A hyperlipoproteinemia. Am J Clin Nutr 1973;26(3):259–63
- Dennis MS, Henzel WJ, Pitti RM, et al. Platelet glycoprotein Ilb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci USA 1990;87(7):2471–5